These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3432166)

  • 21. Determination of binding constants and stoichiometries for platinum anticancer drugs and serum transport proteins by capillary electrophoresis using the Hummel-Dreyer method.
    Rudnev AV; Aleksenko SS; Semenova O; Hartinger CG; Timerbaev AR; Keppler BK
    J Sep Sci; 2005 Feb; 28(2):121-7. PubMed ID: 15754818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elementary pharmacokinetics in clinical practice. 6: Drug concentration monitoring.
    Paxton JW
    N Z Med J; 1982 Mar; 95(703):150-3. PubMed ID: 6952127
    [No Abstract]   [Full Text] [Related]  

  • 23. Benoxaprofen: plasma binding and binding interactions with some drugs and endogenous compounds.
    Albengres E; Urien S; Kusmierek J; Tillement JP
    Eur J Rheumatol Inflamm; 1982; 5(2):87-97. PubMed ID: 6806105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro binding study of gemfibrozil to human serum proteins and erythrocytes: interactions with other drugs.
    Hamberger C; Barre J; Zini R; Taiclet A; Houin G; Tillement JP
    Int J Clin Pharmacol Res; 1986; 6(6):441-9. PubMed ID: 3468088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of the binding parameters of drug to protein by equilibrium dialysis/piezoelectric quartz crystal sensor.
    Zhou A; He D; Nie LH; Yao SZ
    Anal Biochem; 2000 Jun; 282(1):10-5. PubMed ID: 10860493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Plasma binding of drugs in chronic renal failure].
    Riant P; Barre J; Albengres E; Lemaire M; Tillement JP
    Nephrologie; 1986; 7(3):89-93. PubMed ID: 3774085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of tiaprofenic acid to human sera and isolated serum proteins.
    Nilsen OG; Storhaug A; Dale O
    Arzneimittelforschung; 1985; 35(6):984-7. PubMed ID: 4026926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progabide and SL 75102 binding to plasma proteins and red blood cells in humans.
    Hamberger C; Barre J; Brandebourger M; Urien S; Taiclet A; Thenot JP; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):178-84. PubMed ID: 3583466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methotrexate serum binding in rheumatoid arthritis.
    Claudepierre P; Urien S; Chevalier X; Chassany O; Larget-Piet B; Tillement JP
    Int J Clin Pharmacol Ther; 1994 Mar; 32(3):113-5. PubMed ID: 8205370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of erythromycin base to human plasma proteins.
    Prandota J; Tillement JP; d'Athis P; Campos H; Barre J
    J Int Med Res; 1980; 8 Suppl 2():1-8. PubMed ID: 7429002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computer analysis of the pharmacokinetic parameters of EGYT-475, a new antidepressant agent.
    Fehér L; Fonyó M; Magyar K
    Pol J Pharmacol Pharm; 1987; 39(2):167-71. PubMed ID: 3432164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding.
    Curran RE; Claxton CR; Hutchison L; Harradine PJ; Martin IJ; Littlewood P
    Drug Metab Dispos; 2011 Mar; 39(3):551-7. PubMed ID: 21098647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of volume shifts on drug binding during equilibrium dialysis: correction and attenuation.
    Lima JJ; MacKichan JJ; Libertin N; Sabino J
    J Pharmacokinet Biopharm; 1983 Oct; 11(5):483-98. PubMed ID: 6668555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proceedings: Factors responsible for different binding of drugs to plasma proteins of newborn and adults.
    Stickel H; Kurz H; Michels H
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R67. PubMed ID: 1143476
    [No Abstract]   [Full Text] [Related]  

  • 35. Protein binding properties of prazosin.
    Hobbs DC; Twomey TM
    Res Commun Chem Pathol Pharmacol; 1979 Jul; 25(1):189-92. PubMed ID: 451356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of drugs to tissues.
    Kurz H; Fichtl B
    Drug Metab Rev; 1983; 14(3):467-510. PubMed ID: 6347594
    [No Abstract]   [Full Text] [Related]  

  • 37. Validation of 96-well equilibrium dialysis with non-radiolabeled drug for definitive measurement of protein binding and application to clinical development of highly-bound drugs.
    Zamek-Gliszczynski MJ; Ruterbories KJ; Ajamie RT; Wickremsinhe ER; Pothuri L; Rao MV; Basavanakatti VN; Pinjari J; Ramanathan VK; Chaudhary AK
    J Pharm Sci; 2011 Jun; 100(6):2498-507. PubMed ID: 21213309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calculation of drug concentration in plasma after equilibrium dialysis.
    Giacomini KM; Abang A; Blaschke TF
    Br J Clin Pharmacol; 1982 Nov; 14(5):752-4. PubMed ID: 7138760
    [No Abstract]   [Full Text] [Related]  

  • 39. Ultrafiltration vs equilibrium dialysis for determination of free fraction.
    Bowers WF; Fulton S; Thompson J
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():49-60. PubMed ID: 6705427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-isotopic spectrophotometric determination of the unbound fraction of drugs in serum.
    Lim CF; Wynne KN; Barned JM; Topliss DJ; Stockigt JR
    J Pharm Pharmacol; 1986 Nov; 38(11):795-800. PubMed ID: 2879008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.